Versavo+ 400 mg Infusion 16 ml is an anti-cancer medicine used in the treatment of metastatic breast cancer, non-small cell lung cancer, kidney cancer, cervical cancer, epithelial ovarian, fallopian tube, or primary peritoneal cancer, cancer of colon and rectum. This medicine works on vascular endothelial growth factor and causes blood vessels to grow within tumours which provide oxygen and nutrients to the tumour. Common side effects include loss of appetite, constipation, fever, nosebleeds, change in speech, and taste.